ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,288 | +8.9% | 22,180 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $1,183 | +35.5% | 21,980 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $873 | -1.2% | 21,980 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $884 | -99.9% | 21,980 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $706,000 | +8.8% | 21,980 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $649,000 | +6.0% | 21,880 | +0.5% | 0.00% | +100.0% |
| Q1 2022 | $612,000 | -38.7% | 21,780 | +0.5% | 0.00% | -50.0% |
| Q4 2021 | $999,000 | +39.7% | 21,680 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $715,000 | -8.0% | 21,780 | -1.8% | 0.00% | 0.0% |
| Q2 2021 | $777,000 | -7.3% | 22,180 | -4.3% | 0.00% | 0.0% |
| Q1 2021 | $838,000 | +20.9% | 23,180 | -2.9% | 0.00% | 0.0% |
| Q4 2020 | $693,000 | +0.3% | 23,880 | -2.5% | 0.00% | 0.0% |
| Q3 2020 | $691,000 | -15.5% | 24,480 | -3.2% | 0.00% | 0.0% |
| Q2 2020 | $818,000 | -20.6% | 25,280 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $1,030,000 | -34.2% | 25,280 | -0.4% | 0.00% | -25.0% |
| Q4 2019 | $1,565,000 | -15.0% | 25,380 | +0.4% | 0.00% | -20.0% |
| Q3 2019 | $1,842,000 | -11.4% | 25,280 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $2,078,000 | +18.7% | 25,280 | +1.8% | 0.01% | +25.0% |
| Q1 2019 | $1,751,000 | +56.6% | 24,828 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $1,118,000 | -22.5% | 24,828 | -2.7% | 0.00% | 0.0% |
| Q3 2018 | $1,443,000 | -19.2% | 25,528 | -4.5% | 0.00% | -25.0% |
| Q2 2018 | $1,785,000 | +9.4% | 26,728 | -4.6% | 0.00% | 0.0% |
| Q1 2018 | $1,632,000 | -9.6% | 28,028 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,806,000 | +29.5% | 28,028 | +5.4% | 0.00% | +33.3% |
| Q3 2017 | $1,395,000 | +12.1% | 26,585 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,244,000 | -12.7% | 26,585 | -7.6% | 0.00% | -25.0% |
| Q1 2017 | $1,425,000 | -18.9% | 28,785 | -0.7% | 0.00% | -20.0% |
| Q4 2016 | $1,757,000 | -8.6% | 28,985 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $1,923,000 | +24.0% | 28,985 | +4.3% | 0.01% | +25.0% |
| Q2 2016 | $1,551,000 | +65.9% | 27,785 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $935,000 | -26.0% | 27,785 | -0.7% | 0.00% | -33.3% |
| Q4 2015 | $1,263,000 | +16.8% | 27,985 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $1,081,000 | -34.7% | 27,372 | +2.6% | 0.00% | -25.0% |
| Q2 2015 | $1,655,000 | +188.8% | 26,672 | +191.4% | 0.00% | +300.0% |
| Q1 2015 | $573,000 | – | 9,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |